Patient-focused network integration in biopharma strategic imperatives for the years ahead
by
 
Handfield, Robert B.

Title
Patient-focused network integration in biopharma strategic imperatives for the years ahead

Author
Handfield, Robert B.

ISBN
9781466555488

Publication Information
Boca Raton : Taylor & Francis, 2013.

Physical Description
xiii, 183 p. : ill.

Contents
ch. 1. Patient-focused network integration in the life sciences -- ch. 2. An evolutionary view of healthcare network integration -- ch. 3. Healthcare reform and the provider challenges ahead -- ch. 4. Supply chain network analytics for the healthcare industry assessing best of breed -- ch. 5. Electronic collaboration in life sciences supply networks -- ch. 6. Maturing the clinical trial supply chain -- ch. 7. Blueprint for the future.

Abstract
"Preface This book started out as an interesting set of conversations with some very insightful and intelligent people. For twenty-five years, I've studied supply chains in almost every industry, including oil and gas, automotive, electronics, industrial production, and even financial services. And every time I met with executives, I met with the same statements: "We're different-- you don't understand." But in the end, after spending enough time with these executives, it became clear that the same principles of supply chain management applied. Perhaps a different context, different terminology, but in the end, the same rules applied. When I started dabbling in healthcare, I originally encountered the same sets of objections. "Healthcare is different," I would hear, "After all, you have to consider the patient." But as I spent more and more time with healthcare executives, I only rarely heard the patient mentioned in the discussion. More often than not, the discussion focused on compliance, reimbursement, diagnosis-related groups (DRGs), and other terms that had very little to do with patient care. And as I studied the industry more, it became clear that organizations in the healthcare value chain, from the patient through hospitals, wholesalers, through insurance payers, manufacturers, and finally research and development (R&D), were not very well connected at all"-- Provided by publisher.

Subject Term
Pharmaceutical biotechnology.
 
Pharmaceutical biotechnology industry.
 
Biological products -- Therapeutic use.
 
Communication in pharmacy.

Electronic Access
Distributed by publisher. Purchase or institutional license may be required for access.


LibraryMaterial TypeItem BarcodeShelf Number[[missing key: search.ChildField.HOLDING]]Status
Online LibraryE-Book285425-1001ONLINEElektronik Kütüphane